Cargando…
CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade
CTLA-4 is essential for immune tolerance. Heterozygous CTLA4 mutations cause immune dysregulation evident in defective regulatory T cells with low levels of CTLA-4 expression. Biallelic mutations in LRBA also result in immune dysregulation with low levels of CTLA-4 and clinical presentation indistin...
Autores principales: | Garcia-Perez, Josselyn E., Baxter, Ryan M., Kong, Daniel S., Tobin, Richard, McCarter, Martin, Routes, John M., Verbsky, James, Jordan, Michael B., Dutmer, Cullen M., Hsieh, Elena W. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532297/ https://www.ncbi.nlm.nih.gov/pubmed/31156616 http://dx.doi.org/10.3389/fimmu.2019.00998 |
Ejemplares similares
-
Screening for severe combined immunodeficiency in neonates
por: Kelly, Brian T, et al.
Publicado: (2013) -
CTLA-4 blockade: therapeutic potential in cancer treatments
por: Tarhini, Ahmad A, et al.
Publicado: (2010) -
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
por: Wada, Satoshi, et al.
Publicado: (2013) -
Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023) -
Protective Immunity to Nematode Infection Is Induced by CTLA-4 Blockade
por: McCoy, Kathy, et al.
Publicado: (1997)